CageSaulJohnsonMD

PubMed

• 12 citations
  Proteasome Inhibition Induces Both Antioxidant and Hb F Responses in Sickle Cell Disease Via the Nrf2 Pathway
  Vinod Pullarkat, Zhuo Meng, Stanley M. Tahara, Cage S. Johnson, Vijay K. Kalra> ;Hemoglobin. 2014 May 14
• 211 citations
  Neuropsychological dysfunction and neuroimaging abnormalities in neurologically intact adults with sickle cell anemia.
  Elliott Vichinsky, Lynne Neumayr, Jeffrey I. Gold, Michael W. Weiner, Randall R. Rule, Diana Truran, Jeffrey Kasten, Barry E. Eggleston, Karen Kesler, Lillian McMahon,...> ;JAMA. 2010 May 12
• 272 citations
  Definitions of the phenotypic manifestations of sickle cell disease
  Samir K. Ballas, Susan Lieff, Lennette Benjamin, Carlton Dampier, Matthew M. Heeney, Carolyn Hoppe, Cage S. Johnson, Zora R. Rogers, Kim Smith-Whitley, Winfred C. Wang...> ;American Journal of Hematology. 2009 Sep 24
• 7 citations
  A novel high-throughput screening assay for sickle cell disease drug discovery.
  Eszter Pais, John Cambridge, Cage S. Johnson, Herbert J. Meiselman, Timothy C. Fisher, Tamas Alexy> ;Journal of Biomolecular Screening. 2009 Apr 1
• 24 citations
  Sickle Cell Disease Summit: From clinical and research disparity to action
  Kathryn L. Hassell, Betty S. Pace, Winfred C. Wang, Roshni Kulkarni, Naomi L.C. Luban, Cage S. Johnson, James R. Eckman, Peter A. Lane, William G. Woods> ;American Journal of Hematology. 2009 Jan 1
• 6 citations
  Development and validation of SIMS: An instrument for measuring quality of life of adults with sickle cell disease
  Patricia Adams-Graves, Kimberly D. Lamar, Cage S. Johnson, Pat Corley> ;American Journal of Hematology. 2008 Jul 1
• 41 citations
  Rheologic behavior of sickle and normal red blood cell mixtures in sickle plasma: implications for transfusion therapy.
  Tamas Alexy, Eszter Pais, Jonathan K. Armstrong, Herbert J. Meiselman, Cage S. Johnson, Timothy C. Fisher> ;Transfusion. 2006 Jun 1
• 435 citations
  Outcome of sickle cell anemia: a 4-decade observational study of 1056 patients.
  Darleen R. Powars, Linda S. Chan, Alan L. Hiti, Emily Ramicone, Cage S. Johnson> ;Medicine. 2005 Nov 1
• 23 citations
  The acute chest syndrome.
  Cage S. Johnson> ;Hematology/oncology Clinics of North America. 2005 Oct 1
• 30 citations
  Arterial blood pressure and hyperviscosity in sickle cell disease
  Cage S. Johnson> ;Hematology/oncology Clinics of North America. 2005 Oct 1
• 60 citations
  L-Glutamine therapy reduces endothelial adhesion of sickle red blood cells to human umbilical vein endothelial cells
  Yutaka Niihara, Neil M. Matsui, Yamin M Shen, Dean A Akiyama, Cage S. Johnson, M Alenor Sunga, John Magpayo, Stephen H. Embury, Vijay K. Kalra, Seong H. Cho, Kouichi R...> ;BMC Blood Disorders. 2005 Jul 25
• 216 citations
  Mechanism of monocyte activation and expression of proinflammatory cytochemokines by placenta growth factor
  Suresh K. Selvaraj, Ranjit K. Giri, Natalya Perelman, Cage S. Johnson, Punam Malik, Vijay K. Kalra> ;Blood. 2003 Aug 15
• 87 citations
  Outcome in hemoglobin SC disease: A four-decade observational study of clinical, hematologic, and genetic factors
  Darleen R. Powars, Alan L. Hiti, Emily Ramicone, Cage S. Johnson, Linda Chan> ;American Journal of Hematology. 2002 Jul 1
• 28 citations
  Cobalt chloride-induced signaling in endothelium leading to the augmented adherence of sickle red blood cells and transendothelial migration of monocyte-like HL-60 cel...
  Chand Sultana, Yamin Shen, Cage S. Johnson, Vijay K. Kalra> ;Journal of Cellular Physiology. 1999 Apr 1
• 95 citations
  Interaction of sickle erythrocytes with endothelial cells in the presence of endothelial cell conditioned medium induces oxidant stress leading to transendothelial mig...
  Chand Sultana, Yamin Shen, V. Rattan, Cage S. Johnson, Vijay K. Kalra> ;Blood. 1998 Nov 15
• 24 citations
  Platelet-activating factor in plasma of patients with sickle cell disease in steady state
  Shin O. Oh, Basil O. Ibe, Cage S. Johnson, Joseph Kurantsin-mills, J.Usha Raj> ;The Journal of Laboratory and Clinical Medicine. 1997 Aug 1
• 37 citations
  Infectious Disease Testing for Blood Transfusions: NIH Consensus Development Panel on Infectious Disease Testing for Blood Transfusions
  Jane F. Desforges, Freydoon Athari, E. Shannon Cooper, Cage S. Johnson, Stanley M. Lemon, Karen L. Lindsay, Jeffrey McCullough, Kenneth McIntosh, Robert K. Ross, Carol...> ;JAMA. 1995 Nov 1
• 12 citations
  Blood Transfusions and Immunophenotypic Alterations of Lymphocyte Subsets in Sickle Cell Anemia
  Wing Yen Wong, Darleen R. Powars, Eva Operskalski, Joseph Hassett, John W. Parker, Sharada A. Sarnaik, Charles H. Pegelow, Margaret W. Hilgartner, Cage S. Johnson, Yi ...> ;Blood. 1995 Apr 15
• 42 citations
  Beta-S gene cluster haplotypes modulate hematologic and hemorheologic expression in sickle cell anemia. Use in predicting clinical severity.
  D. R. Powars, H. J. Meiselman, T. C. Fisher, A. Hiti, Cage S. Johnson> ;The American Journal of Pediatric Hematology/oncology. 1994 Feb 1
• 14 citations
  Effect of blood transfusion on serum iron and transferrin saturation.
  Sunita Saxena, Ira A. Shulman, Cage S. Johnson> ;Archives of Pathology & Laboratory Medicine. 1993 Jun 1
• 34 citations
  Multisystem Damage Associated With Tricorporal Priapism in Sickle Cell Disease
  J. Randolph Sharpsteen, Darleen R. Powars, Cage S. Johnson, Zora R. Rogers, W. Donald Williams, Ralph J. Posch> ;The American Journal of Medicine. 1993 Mar 1
• 15 citations
  Iron-deficiency anemia: A medically treatable chronic anemia as a model for transfusion overuse
  Sunita Saxena, Arthur P. Rabinowitz, Cage S. Johnson, Ira A. Shulman> ;The American Journal of Medicine. 1993 Feb 1
• 58 citations
  Polysaccharide encapsulated bacterial infection in sickle cell anemia: a thirty year epidemiologic experience.
  Wing Yen Wong, Darleen R. Powars, Linda Chan, Alan L. Hiti, Cage S. Johnson, Gary D. Overturf> ;American Journal of Hematology. 1992 Mar 1
• 3 citations
  Retinal vessel autoregulation in sickle cell patients.
  Jan C. van Meurs, Joan Schwoerer, Bernard Schwartz, Paul G.H. Mulder, Herbert J. Meiselmann, Cage S. Johnson> ;Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie. 1992 Jan 1
• 234 citations
  Chronic Renal Failure in Sickle Cell Disease: Risk Factors, Clinical Course, and Mortality
  Darleen R. Powars, Donna D. Elliott-Mills, Linda Chan, Joyce C. Niland, Alan L. Hiti, Lawrence M. Opas, Cage S. Johnson> ;Annals of Internal Medicine. 1991 Oct 15
• Join now to see all

Journal Articles

• Definitions of the phenotypic manifestations of sickle cell disease  
  Ballas SK, Lieff S, Benjamin LJ, Dampier CD, Heeney MM, Hoppe C, Johnson CS, Rogers ZR, Smith-Whitley K, Wang WC, Telen MJ, on Behalf of the Investigators at the Compr..., American Journal of Hematology, 1/1/2010
• Neuropsychological Dysfunction and Neuroimaging Abnormalities in Neurologically Intact Adult Patients with Sickle Cell Anemia  
  Vichinsky EP, Neumayr LD, Gold JI, Weiner MW, Rule RR, Truran D, Kasten J, EgglestonB, Kesle rK, McMahon L, Orringer EP, Harrington T, Kalinyak K, De Castro LM, Kutlar..., JAMA, 1/1/2010
• Sickle cell disease summit: From clinical and research disparity to action  
  Hassell K, Pace B, Wang W, Kulkarni R, Luban N, Johnson CS, Eckman J, Lane P, Woods WG, American Journal of. Hematology, 1/1/2009
• A novel high-throughput screening assay for sickle cell disease drug discovery  
  Pais E, Cambridge JS, Johnson CS, Meiselman HJ, Fisher TC, Alexy T, Journal of Biomolecular Screening, 1/1/2009
• Development and validation of SIMS: An instrument for measuring quality of life of adults with sickle cell disease  
  Adams-Graves P, Lamar K, Johnson C, Corley P, Am J Hematol, 1/1/2008
• Rheological behavior of sickle and normal red blood cell mixtures in sickle plasma: Implications for transfusion therapy  
  Alexy T, Pais E, Armstrong JK, Wenby RB, Meiselman HJ, Johnson CS, Fisher TC, Transfusion, 1/1/2006
• A novel role of hypoxia-inducible factor in cobalt chloride- and hypoxia-mediated expression of IL-8 chemokine in human endothelial cells  
  Kim KS, Rajagopal V, Gonsalves C, Johnson C, Kalra VK, Journal of Immunology, 1/1/2006
• Bone Marrow Embolism in Sickle Cell Disease: A Review  
  Dang NC, Johnson C, Eslami-Farsani M, Haywood LJ, American Journal of Hematology, 1/1/2005
• Myocardial injury or infarction associated with fat embolism in sickle cell disease: A report of three cases with survival  
  Dang NC, Johnson C, Eslami-Farsani M, Haywood LJ, American Journal of Hematology, 1/1/2005
• Outcome of sickle cell anemia: A 4-decade observational study of 1056 patients  
  Powars DR, Chan LS, Hiti A, Ramicone E, Johnson C, Medicine, 1/1/2005
• L-glutamine therapy reduces endothelial adhesion of sickle red blood cells to human umbilical vein endothelial cells  
  Niihara Y, Matsui NM, Shen YM, Akiyama DA, Johnson CS, Sunga MA, Magpayo J, Embury SH, Kalra VK, Cho SH, Tanaka KR, BMC Blood Disorders, 1/1/2005
• Mechanism of monocyte activation and expression of proinflammatory cytochemokines by placenta growth factor  
  Selvaraj SK, Giri RK, Perelman N, Johnson C, Malik P, Kalra VK, Blood, 1/1/2003
• Outcome in hemoglobin SC disease: A four–decade observational study of clinical, hematologic, and genetic factors  
  Powars DR, Hiti A, Ramicone E, Johnson C, Chan L, American Journal of Hematology, 1/1/2002
• Cobalt chloride-induced signaling in endothelium leading to the augmented adherence of sickle red blood cells and transendothelial migration of monocyte-like HL-60 cel...  
  Sultana C, Shen Y, Johnson C, Kalra VK, Journal of Cellular Physiology, 1/1/1999
• Renal complications of the sickle cell diseases  
  Johnson C, Hematology, 1/1/1999
• Interaction of sickle erythrocytes with endothelial cells in the presence of endothelial cell conditioned medium induces oxidant stress leading to trans endothelial mi...  
  Sultana C, Shen Y, Rattan V, Johnson C, Kalra VK, Blood, 1/1/1998
• Pulmonary complications raise risks in sickle cell disease  
  Weil J, Thomas A, Castro O, Johnson CS, Pulmonary Reviews, 1/1/1998
• Platelet activating factor in sickle cell hemoglobinopathy  
  Ibe BO, Shin OO, Johnson C, Kurantsin-Mills J, Raj JU, Journal of Laboratory and Clinical Medicine, 1/1/1997
• The sickle cell delayed hemolytic reaction syndrome  
  Petz LD, Calhoun L, Shulman IA, Johnson C, Herron RM, Transfusion, 1/1/1997
• The sickle cell hemolytic transfusion reaction syndrome  
  Petz LD, Calhoun L, Shulman I, Johnson CS, Herron CM, Transfusion, 1/1/1997
• Myocardial infarction in sickle cell disease  
  Martin CR, Johnson CS, Cobb C, Tatter D, Haywwood LJ, Journal of the National Medical Association, 1/1/1996
• Infectious disease testing for blood transfusions  
  JAMA, 1/1/1995
• Blood transfusions and immunophenotypic alterations and lymphocyte subsets in sickle cell anemia  
  Wong WY, Powars DR, Operskalski EA, Hassett J, Parker JW, Sarnaik S, Pegelow CH, Hilgartner MW, Johnson CS, Zhou Y, Ku P, Mosley JW, and the Transfusion Safety Study G..., Blood, 1/1/1995
• Beta-S gene cluster haplotypes modulate hematologic and hemorheologic expression in sickle cell anemia  
  Powars DR, Meiselman HJ, Fisher TC, Hiti A, Johnson C, American Journal of Pediatric Hematology/Oncology, 1/1/1994
• Iron deficiency anemia: A medically treatable chronic anemia as a model for transfusion overuse  
  Saxena S, Rabinowitz AP, Johnson C, Shulman IA, American Journal of Medicine, 1/1/1993
• Join now to see all

Books/Book Chapters

• Synopsis of Hematology: Including blood diseases in the tropics 
  Editors: I Okpala, C Johnson.CreateSpace, Charleston, SC2010
• Encyclopedia of Public Health 
  Chapter: Sickle Cell Disease 
  Page 6 - 15Johnson CSEditors: Heggenhougen K, Quah S.Academic Press, San Diego2008
• Tropical Lung Disease 
  Chapter: Johnson CS 
  Page 475 - 505Johnson CSEditors: Sharma OP.Taylor & Francis, New York2005
• Sickle Cell disease, Hematology/Oncology Clinics of North America 
  Chapter: Arterial blood pressure and hyperviscosity in sickle cell disease 
  Page 827 - 837Johnson CSW.B. Saunders Company, Philadelphia2005
• Sickle Cell disease, Hematology/Oncology Clinics of North America 
  Chapter: The acute chest syndrome 
  Page 857 - 879Johnson CSW.B. Saunders Company, Philadelphia2005
• Practical Management of Haemoglobinopathies 
  Chapter: The Liver in Sickle Cell Disease 
  Johnson CSEditors: Okpala IE.Blackwell Publishing Ltd.2004
• Interactions of Blood and Pulmonary Circulation 
  Chapter: Mechanisms of monocyte migration following sickle erythrocyte adherence to endothelium 
  Kalra VK, Selvaraj S, Johnson CSEditors: Weir EK, Reeve HL, Reeves JT.Futura Publishing Company, Armonk, NY2002
• Medical, Psychosocial and Vocational Aspects of Disability 
  Chapter: Johnson CS 
  Johnson CSEditors: Brodwin MG, Tellez F, Brodwin SK.Elliott & Fitzpatrick, Inc.Edition 2nd ,2002
• The Management of Sickle Cell Disease 
  Chapter: Gallbladder and Liver 
  Johnson CSNIH PublicationEdition 4th ,2002
• Vascular Protection 
  Chapter: Sickle erythrocyte interaction with endothelial cells causes endothelial dysfunction 
  Kalra VK, Johnson CSEditors: Rubanyi G, Dzau V, Cooke J.Harwood Academic Publishers2000
• Hematology/Oncology Clinics of North America 
  Chapter: Sickle Cell disease 
  Editors: Charache S, Johnson CS.W.B. Saunders Company, Philadelphia1996
• Sickle Cell disease, Hematology/Oncology Clinics of North America 
  Chapter: Priapsim 
  Powars DR, Johnson CSEditors: Charache S, Johnson CS.W.B. Saunders Company, Philadelphia1996
• Managment and Therapy of Sickle Cell Disease 
  Editors: Reid CD, Charache S, Lubin B, Johnson C, Ohene-Frempong K.NIH PublicationEdition 3rd ,1995
• Conn's Current Therapy 
  Chapter: Sickle Cell Disease 
  Johnson CSEditors: Rakel R.W.B. Saunders Company1993
• Medical, Psychosocial and Vocational Aspects of Disability 
  Chapter: Medical, Psychosocial and Vocational Aspects of Disability 
  Johnson CS, Francis, Jr. RBEditors: Brodwin MG, Tellez F, Brodwin SK.Elliott & Fitzpatrick, Inc.1992
• Blood rheology and hyperviscosity syndromes 
  Chapter: Rheology of the sickle cell disorders 
  Page 747 - 775Stuart J, Johnson CSEditors: GDO Rowe.Balliere's Clinical Haematology1987
• Lessons for Animal Diabetes 
  Chapter: Effect of thymus transplantation on the spontaneous diabetic syndrome in athymic nude mice 
  Zeidler A, Kumar D, Johnson C, Parker JEditors: Shafir E, Renold AE.John Libbey1984
• Handbook of Severe Disability 
  Chapter: Sickle cell disease 
  Johnson CSEditors: Stolov WC, Clovers MR.U.S. Government Printing Office1981
• Red Cell Rheology 
  Chapter: Human red cell protein kinase in normal subjects and patients with hereditary spherocytosis, sickle cell disease, and autoimmune hemolytic anemia 
  Beutler E, Guinto E, Johnson CEditors: Bessis M, Shohet SB, Mohandas N.Springer - Verlag1978
• Join now to see all

Abstracts/Posters

• Mechanism of PlGF mediated monocyte activation and its inhibition by curcumin in sickle cell disease
  Kalra VK, Rajagopal V, Kim KS, Perelman N, Madigan C, Johnson CS, and Malik P, 28th Annual Meeting of the National Sickle Cell Disease Program, 4/9/2005
• Rajagopal V, Kim KS, Gonsalves C, Madigan C, Johnson CS, Malik P, and Kalra VK
  Rajagopal V, Kim KS, Gonsalves C, Madigan C, Johnson CS, Malik P, and Kalra VK, Plenary Session, 28th Annual Meeting of the National Sickle Cell Disease Program, 4/9/2005
• Polymer-Coated RBC for In Vivo Microcirculatory Studies of RBC Aggregation: Enhanced Aggregation in Native Plasma
  Meiselman, H.J; Armstrong, J.K.; Kim, S., Johnson, P.C., FASEB J, 1/1/2005
• Quality of Life and Sickle Cell Disease
  Adams-Graves, P, Johnson, C, Corley, P, Lamar, K., Blood, 1/1/2005
• Hydroxyurea induced exression of erythrocyte anion exchange protein (AE1) and gamma globin in cultured erythroid progenitor cells
  Green GA, Braden BR, Mba O, Chivira SA, Ramezani L, Johnson CS, Blood, 1/1/2005
• Tendinitis/Bursitis syndrome in patients with sickle cell disease
  Montgomery C, Corley PL, Johnson CS, 27th Annual Meeting of the National Sickle Cell Disease Program, 4/18/2004
• Fisher TC, Hiti AL, Kurtzman T, Zeng L, Meiselman HJ, Johnson CS, Coates TD, Malik P
  Fisher TC, Hiti AL, Kurtzman T, Zeng L, Meiselman HJ, Johnson CS, Coates TD, Malik P, 27th Annual Meeting of the National Sickle Cell Disease Program, 4/18/2004
• Oral L-glutamine therapy reduces adherence of sickle red blood cells to human umbilical vein endothelial cells
  Niihara Y, Matsui NM, Sunga MA, Magpayo J, Embury SH, Tanaka KR, Johnson CS, Blood, 1/1/2000
• Induction of erythrocyte anion exchange [AE1] protein expression by hydroxyurea
  Green GY, Johnson CS, Blood, 1/1/2000
• Deformability and superoxide radical production of fractionated erythrocytes in sickle cell disease
  Novak, Z., van der Waart, F., Fisher, T.C., Johnson, C.S.,Pinter, S., Meiselman, H.J., Pediatric Research, 1/1/1995
• Polymorphonuclear leucocyte deformability, f-actin content and CD 16 expression are abnormal in sickle cell disease and correlate with severity
  Fisher TC, Coates TD, Pecsvardy Z, Fabok A, Deemer K, Johnson CS, Meiselman HJ, Clinical Hemorheology, 1/1/1993
• Sickle erythrocytes exhibit increased rheologic sensitivity to oxidative damage
  Novak Z, Fisher TC, Johnson CS, Meiselman HJ, Clinical Hemorheology, 1/1/1993
• SS RBC rheologic heterogeneity correlates with density and disease severity
  van der Waart FJM, Fisher TC, Johnson CS, Meiselman HJ, Clinical Hemorheology, 1/1/1993
• Hemorheological correlates of beta-gene haplotypes in sickle cell anemia
  Wenby RB, Fisher TC, Hiti AL, Johnson CS, Meiselman HJ, Clinical Hemorheology, 1/1/1993
• Poloxamer 188 (RheothRx injection) reduces RBC aggregation in blood from patients with acute myocardial infarction
  Toth K, Haywood LJ, Johnson CS, Meiselman HJ, Clinical Hemorheology, 1/1/1993
• Immunophenotypic alterations of lymphocyte subsets in sickle cell anemia (SCA)
  Wong WY, Powars DR, and the Transfusion Safety Study Group (TSS), Blood, 1/1/1993
• Neutrophil deformability and FcRIII expression correlate with clinical severity (beta globin haplotype) in sickle cell disease
  Coates TD, Fisher TC, Pecsvardy Z, Fabok A, Deemer K, Hiti AL, Johnson CS, Meiselman HJ, Blood, 1/1/1992
• Increased rheologic sensitivity of sickle erythrocytes to oxidative damage
  Novak Z, Fisher TC, Johnson CS, Meiselman HJ, Blood, 1/1/1992
• Heterogeneity of sickle RBC deformability evaluated by a new micropore filtration method
  van der Waart FJM, Fisher TC, Johnson CS, Meiselman HJ, Blood, 1/1/1992
• Neutrophils have increased surface expression of adhesion receptors and decreased deformability in sickle cell disease
  Coates TD, Fisher TC, Pecsvardy Z, Fabok A, Coblentz JG, Johnson CS, Meiselman HJ, Blood, 1/1/1991
• Hemorheological effects of nonionic copolymer surfactants
  Carter C, Cooke BM, Fisher TC, Hamai H, Johnson CS, Kalra VK, Meiselman HJ, Nash GB, Sowemimo-Coker SO, Stuart J, Toth K, Wenby RB, Clinical Hemorheology, 1/1/1991
• Effects of cellular factors on the aggregation behavior of sickle (HbSS) erythrocytes
  Sowemimo-Coker SO, Johnson CS, Meiselman HJ, Clinical Hemorheology, 1/1/1991
• The in vitro effect of poloxamer 188 (RheothRx) on red blood cell aggregation in patients with acute myocardial infarction
  Toth K, Wenby RB, Haywood LJ, Johnson C, Meiselman HJ, Perfusion, 1/1/1991
• Procaine hydrochloride improves the deformability of oxygenated sickle cells
  Lockhart JC, Bauer M, Meiselman HJ, Johnson CS, Journal of the Association of Academic Minority Physicians, 1/1/1990
• Intravenous infusion of procaine hydrochloride for the acute pain of sickle cell anemia
  Johnson CS, Lockhart JC, Bauer M, Meiselman HJ, Journal of the Association of Academic Minority Physicians, 1/1/1990
• Join now to see all

Lectures

• Health Maintenance for Adults with Sickle Cell Disease 
  New York Methodist Hospital, Brooklyn, NY - 5/2/2008
• Hypercoaguability in Sickle Cell Disease-Perception or Reality 
  University of South Alabama, Mobile, AL - 4/19/2008
• Sickle cell disease, Meet-the-Professor 
  San Diego, CA, 2003; San Diego, CA, 2004; Orlando, FL, 2006 - 12/9/2006
• Blood pressure and cardiac function in sickle cell disease 
  King's College London, St. Thomas' Hospital Campus, London, UK - 10/11/2004
• Hepato-biliary complications of the sickling Disorders 
  King's College London, St. Thomas' Hospital Campus, London, UK - 10/2/2000
• Renal complications of the sickle cell diseases 
  New Orleans, L - 12/4/1999
• Sickle cell disease 
  NHLBI, NIH Mini-Medical School, Washington, DC - 6/18/1998
• Pulmonary hypertension in sickle cell disease 
  Chicago, IL - 4/28/1998
• Rheology of the sickling disorders and its impact on blood pressure 
  Meharry Medical College, Nashville, TN - 4/17/1997
• Rheology of the sickling disorders 
  Duke University, Durham, NC - 4/3/1997
• Pulmonary complications of sickle cell disease 
  1/1/1988
• Join now to see all

Other

• Hydroxyurea treatment for sickle cell disease 
  
  1/1/2008
• Cerebral Infarction in the Sickle Cell Diseases: Current Concepts and Therapeutic Guidelines 
  Johnson CS
  http://www.medscape.com/viewarticle/496546
  12/30/2004
• Modulation of Fetal Hemoglobin in Sickle Cell Anemia 
  Johnson CS
  http://www.medscape.com/viewarticle/466371
  12/30/2003
• Gall Bladder and Liver Disorders in Sickle Cell Disease: a Critical Review 
  Johnson CS
  http://sickle.bwh.harvard.edu/liver.html
  1/1/2001
• Infectious disease testing for blood transfusions 
  
  1/1/1995
• Sickle cell disease: the acute chest syndrome 
  Johnson, CS
  http://sickle.bwh.harvard.edu/acutechest.html
  1/1/1995
• Acute myocardial infarction in sickle cell anemia 
  Martin C, Cobb C, Tatter D, Johnson C, Haywood LJ
  1/1/1984
• Join now to see all